1. A study of the drug tildrakizumab for plaque psoriasis. (1st June 2020) Authors: Kimball, A.B.; Papp, K.A.; Reich, K.; Gooderham, M.; Li, Q.; Cichanowitz, N.; La Rosa, C.; Blauvelt, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0903 Efficacy of tildrakizumab in etanercept partial or nonresponders. (12th June 2018) Authors: Crowley, J.; Papp, K.A.; Hong, C.-H.; Parno, J.; Mendelsohn, A.M.; Li, Q.; Cichanowitz, N.; La Rosa, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies. (19th November 2019) Authors: Kimball, A.B.; Papp, K.A.; Reich, K.; Gooderham, M.; Li, Q.; Cichanowitz, N.; La Rosa, C.; Blauvelt, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies. (1st June 2020) Authors: Kimball, A.B.; Papp, K.A.; Reich, K.; Gooderham, M.; Li, Q.; Cichanowitz, N.; La Rosa, C.; Blauvelt, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28. (5th March 2019) Authors: Papp, K.A.; Reich, K.; Blauvelt, A.; Kimball, A.B.; Gooderham, M.; Tyring, S.K.; Sinclair, R.; Thaci, D.; Li, Q.; Cichanowitz, N.; Green, S.; La Rosa, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 6(2019) Page Start: 1098 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials. (1st September 2018) Authors: Blauvelt, A.; Reich, K.; Papp, K.A.; Kimball, A.B.; Gooderham, M.; Tyring, S.K.; Sinclair, R.; Thaçi, D.; Li, Q.; Cichanowitz, N.; Green, S.; La Rosa, C. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials. (4th July 2018) Authors: Blauvelt, A.; Reich, K.; Papp, K.A.; Kimball, A.B.; Gooderham, M.; Tyring, S.K.; Sinclair, R.; Thaçi, D.; Li, Q.; Cichanowitz, N.; Green, S.; La Rosa, C. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0312 Incidence of infections in clinical trials of tildrakizumab for moderate to severe chronic plaque psoriasis. (12th June 2018) Authors: Crowley, J.; Leonardi, C.; Sturgill-Koszycki, S.; Menter, A.; Mendelsohn, A.M.; Li, Q.; Cichanowitz, N.; La Rosa, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0291 Incidence of serious gastrointestinal events and inflammatory bowel disease among tildrakizumab-treated patients with moderate to severe plaque psoriasis: data from 3 large randomised clinical trials. (12th June 2018) Authors: Gooderham, M.; Elewski, B.E.; Pariser, D.M.; Sofen, H.; Mendelsohn, A.M.; Cichanowitz, N.; Li, Q.; La Rosa, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 药物 Tildrakizumab 治疗斑块型银屑病的研究. (1st June 2020) Authors: Kimball, A.B.; Papp, K.A.; Reich, K.; Gooderham, M.; Li, Q.; Cichanowitz, N.; La Rosa, C.; Blauvelt, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗